Factors associated with general practitioner visits for pain in people experiencing chronic pain.


Journal

Journal of primary health care
ISSN: 1172-6156
Titre abrégé: J Prim Health Care
Pays: Australia
ID NLM: 101524060

Informations de publication

Date de publication:
09 2023
Historique:
received: 12 01 2023
accepted: 22 03 2023
medline: 29 9 2023
pubmed: 27 9 2023
entrez: 27 9 2023
Statut: ppublish

Résumé

Introduction Patients with chronic pain (CP) are frequent users of general practitioners (GPs). Aim This study aimed to assess factors associated with the rate of GP visits related to pain in patients with CP. Methods This study used data collected by adult specialist pain management services (SPMS) that participated in the electronic Persistent Pain Outcomes Collaboration (ePPOC) in Australia. Adult patients (18 years or older) with CP (duration greater than 3 months) who were referred to SPMS from the calendar year 2015-2021 were included (N  = 84 829). Results Patients who reported severe anxiety, stress, pain, pain interference, pain catastrophising and severely impaired pain self-efficacy were more likely to seek help from a GP. Patients with longer pain duration had a lower rate of GP visits. The rate of GP visits was 1.22 (IRR = 1.22, 95% CI: 1.19, 1.26) times higher in patients with severe pain severity, compared to patients with mild pain severity. Patients who used opioids were more likely to visit a GP (IRR = 1.32, 95% CI: 1.30, 1.34) than those who were not using opioids. Discussions More than half of the adult CP patients had greater than three GP visits in the 3 months before referral. This study would indicate that some patients may attend their GP to seek an opioid prescription. Given the rising use of opioids nationally, future study is required on opioid users' GP visitation practices. Additionally, the inverse association between pain duration and the rate of GP visits warrants further exploration.

Identifiants

pubmed: 37756231
pii: HC23004
doi: 10.1071/HC23004
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

199-205

Auteurs

Dinberu Shebeshi (D)

Australian Health Services Research Institute, University of Wollongong, Wollongong, NSW, Australia.

Samuel Allingham (S)

Australian Health Services Research Institute, University of Wollongong, Wollongong, NSW, Australia.

Janelle White (J)

Australian Health Services Research Institute, University of Wollongong, Wollongong, NSW, Australia.

Hilarie Tardif (H)

Australian Health Services Research Institute, University of Wollongong, Wollongong, NSW, Australia.

David Holloway (D)

Australian Health Services Research Institute, University of Wollongong, Wollongong, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH